Browsing Tag
non small cell lung cancer
2 posts
How oral Targeted Glue degraders could change dosing paradigms in cancer treatment
Discover how oral Targeted Glue degraders could transform cancer dosing strategies and reshape oncology treatment models. Read the full analysis.
Why Immutep Limited halted its lung cancer trial and how the decision reshapes its immunotherapy strategy (NASDAQ: IMMP)
Immutep Limited halts the TACTI-004 Phase III lung cancer trial. Discover what the futility result means for eftilagimod alfa and LAG-3 immunotherapy.